comparemela.com

Latest Breaking News On - Carsgen therapeutics holdings limited stock code - Page 1 : comparemela.com

CARsgen Announced 2023 Annual Results

/PRNewswire/ March 27, 2024, CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the.

London
City-of
United-kingdom
China
Huadong
Guangdong
Canada
United-states
Shanghai
American
Zonghai-li
Carsgen-therapeutics-holdings-limited-stock-code

CARsgen's Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of.

United-states
China
Shanghai
American
America
Raffaele-baffa
Carsgen-therapeutics-holdings-limited-stock-code
Carsgen-therapeutics-holdings
Therapeutics-holdings-limited
Stock-code
Chief-medical-officer
Antigen-receptort-cell-therapy

CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection

SHANGHAI, Jan. 15, 2024 /PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for

Thailand
Shanghai
China
Raffaele-baffa
National-medical-products-administration
Carsgen-therapeutics-holdings-limited-stock-code
Carsgen-therapeutics-holdings
Therapeutics-holdings-limited
Stock-code
Investigational-new-drug
Chief-medical-officer
Therapeutics-holdings

CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of.

China
Shanghai
Carsgen-therapeutics-holdings-limited-stock-code
Drug-administration
Carsgen-therapeutics-holdings
Therapeutics-holdings-limited
Stock-code
Investigational-new-drug
Therapeutics-holdings
Carsgen-therapeutics
Health-care-amp-hospitals

CARsgen 2022 Interim Results: Innovative CAR T-cell Technologies and Robust Pipeline

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of.

Japan
Shanghai
China
United-states
North-carolina
Research-triangle-park
Jinshan
Sichuan
Xuhui
America
American
Raffaele-baffa

vimarsana © 2020. All Rights Reserved.